Impact of symptom duration on the short- and long-term efficacy of bimekizumab in axial spondyloarthritis: results up to 2 years. Arthritis research & therapy 2026 https://researcherprofiles.org/profile/754170970 41555451 Ramiro S, Proft F, Sengupta R, van Tubergen A, Moltó A, Gensler LS, Kishimoto M, Taieb V, Kavanagh S, Evans S, Navarro-Compán V
